Skip to main content
Premium Trial:

Request an Annual Quote

William Murray Named Division President of Molecular Biology at ABI; Beckman Coulter Names Scott Garrett CEO; Samraat Raha Joins Agilent; Plus More

William Murray has been appointed division president, molecular biology at Applied Biosystems, the company said yesterday. He takes over for Catherine Burzik, the current president of Applied Biosystems, who had been leading the division since the company announced a restructuring last summer. Murraymost recently served as group president of respiratory technologies for Viasys Healthcare. He also has held exec-utive positions at Medtronic. Applied Biosystems also announced other management appointments in the molecular biology division, including naming Carl Hull to the post of vice president and general manager, real-time PCR systems and microarrays. Stephen Kondor was named vice president and general manager, genetic analysis, and Peter Dansky was named senior director and general manager, core PCR and DNA synthesis.

Beckman Coulter has named Scott Garrett as its CEO, effective Feb. 21, the company said last week. Garrett, who is currently president and chief operating officer, will replace current CEO John Wareham, who is retiring. Warehamwill remain as chairman of the board until the annual shareholder meeting to be held April 7, Beckman Coulter said. In addition, Garrett was elected to Beckman's board of directors, effective Jan. 17, raising the number of directors to 12, the company said. Garrett joined Beckman Coulter in 2002. He had previously served as CEO of Garrett Capital Advisors and Kendro Laboratory Products. He also has almost 20 years of experience with Baxter International/American Hospital Supply Corporation, Beckman said.

Stephen Oldfield has left his position of vice president of worldwide marketing for Molecular Devices, Inside Bioassays, a GenomeWeb publication, has learned. A company spokesperson declined to provide details regarding Oldfield's departure. Molecular Devices said it has named Jan Hughes as the new vice president of worldwide marketing. Hughes previously was vice president of product development for Molecular Devices' high-throughput electrophysiology division.

Samraat Raha, former vice president of GE Healthcare's CodeLink microarray product line, has joined Agilent Technologies' Life Science and Chemical Analysis business unit as vice president of field operations for the Americas. He reports to Lon Justice, VP and general manager of worldwide sales, marketing and services. Raha manages sales and marketing for the Americas, including all LSCA markets (Integrated Biology, Pharmaceutical Analysis, Chemical Analysis, Consumables & Services). Raha joined Amersham before the company's acquisition by General Electric and worked there for almost two years before joining Agilent. Previously, he was chief business officer for EraGen of Madison, Wis., and prior to that, he was vice president of discovery services and bioreagents for Incyte Genomics.

Evotec OAI said last week that Mary Tanner has been elected to the company's supervisory board. Tanner has 22 years of senior-level management experience in healthcare and consumer products at Lehman Brothers and Bear Stearns, Evotec said. Tanner retired from Bear Stearns in 2004, and founded Life Sciences Partners, a healthcare investment and advisory firm. Tanner obtained a degree from HarvardUniversityin 1973 in philosophy and related fields, Evotec said.

The Chemical Heritage Foundation (CHF) has selected James D. Watson, co-discoverer of the structure of DNA, to receive the 2005 Othmer Gold Medal. The award ceremony and annual Othmer Gold Medal Luncheon will take place at CHF in Philadelphiaon June 9.

James Bruce has been named CEO of Sciona, a Boulder, Colo.-based developer of DNA screens for common gene variants that affect an individual's response to food, medications, and the environment. Bruce most recently served as president and CEO of Madous, a pharmaceutical/nutraceutical firm. Former Sciona CEO Chris Martin has become the firm's chairman.

James Jordan has joined the Pittsburgh Life Sciences Greenhouse as an executive-in-residence focusing on the development of early-stage companies and commercialization of later-stage technologies and opportunities. Jordanpreviously served as senior vice president of marketing and business development at McKesson, and was a vice president in the USmarketing operations for Johnson & Johnson.

Cy Steinhas joined the scientific advisory board of Berlin-based Atugen. Stein is head of medical genitourinary oncology and professor of medicine, urology and molecular pharmacology at the Albert Einstein College of Medicine. He co-developed Genta's Genasense, an antisense treatment for BCL-2-dependent breast cancer. Stein currently serves as co-editor of the journal Oligonucleotides.

Sirna Therapeuticshas appointed Rebecca Galler Robison to the post of senior director of corporate strategy, a newly created position at the company. Robison most recently served as director of private equity at Invesco Funds Group.

John Lislehas been named CEO of Inpharmatica. He most recently served as CEO of Profile Therapeutics. Malcolm Weir, Inpharmatica's current CEO will remain in the role of chief scientific officer.

David Smith, who served as senior vice president and general counsel of TissueInformatics until its merger with Icoria last February, has joined law firm Pepper Hamilton's intellectual property practice group in Pittsburgh, Pa.

Russell Medford, president and CEO of AtheroGenics, has been elected chair of the Georgia Biomedical Partnership. Medfordalso serves on the biosciences executive committee for the Metro Atlanta Chamber of Commerce, the Southeastern Life Sciences Association board of directors, and the Biotechnology Industry Organization's emerging companies section governing body.

Jim Parinahas been named director of sales and business development for Expression Analysis, the Durham, NC-based firm said last week. He previously was a pharmaceutical business development manager at Applied Biosystems and a sales manager at PerkinElmer.

Fairfield Sensorshas appointed Louise Madden to the position of financial director. She previously served as an accountant with KPMG.

Kristen Andersonhas been named senior vice president of human resources at Abgenix. She joins the firm from Applied Biosystems, where she served as vice president of human resources.

Jonathan Kuwabara-Wagg has joined Pharsight as a senior scientist in the firm's drug development consulting division. He will report to Russell Wada, vice president, drug development consulting services, West Coast and Japan. Kuwabara-Wagg has been a consultant to many institutions and companies including Rockefeller University, Columbia University, Simulation Resources, Scimagix, and the bioinformatics research group at SRI. He previously served as CEO of Zephra and was a senior bioinformatics scientist at Pangea Systems/Double Twist.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.